These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20888650)

  • 1. miRNAs in multiple sclerosis: regulating the regulators.
    Guerau-de-Arellano M; Lovett-Racke AE; Racke MK
    J Neuroimmunol; 2010 Dec; 229(1-2):3-4. PubMed ID: 20888650
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered miRNA expression in T regulatory cells in course of multiple sclerosis.
    De Santis G; Ferracin M; Biondani A; Caniatti L; Rosaria Tola M; Castellazzi M; Zagatti B; Battistini L; Borsellino G; Fainardi E; Gavioli R; Negrini M; Furlan R; Granieri E
    J Neuroimmunol; 2010 Sep; 226(1-2):165-71. PubMed ID: 20637509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
    Severin ME; Lee PW; Liu Y; Selhorst AJ; Gormley MG; Pei W; Yang Y; Guerau-de-Arellano M; Racke MK; Lovett-Racke AE
    Brain; 2016 Jun; 139(Pt 6):1747-61. PubMed ID: 27190026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, regulation and function of microRNAs in multiple sclerosis.
    Ma X; Zhou J; Zhong Y; Jiang L; Mu P; Li Y; Singh N; Nagarkatti M; Nagarkatti P
    Int J Med Sci; 2014; 11(8):810-8. PubMed ID: 24936144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.
    Angerstein C; Hecker M; Paap BK; Koczan D; Thamilarasan M; Thiesen HJ; Zettl UK
    Mol Neurobiol; 2012 Jun; 45(3):520-35. PubMed ID: 22549745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease.
    O'Connor RA; Anderton SM
    J Neuroimmunol; 2008 Jan; 193(1-2):1-11. PubMed ID: 18077005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of translational regulation by microRNAs in multiple sclerosis.
    Junker A
    FEBS Lett; 2011 Dec; 585(23):3738-46. PubMed ID: 21453702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
    Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH
    PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-124a and miR-155 enhance differentiation of regulatory T cells in patients with neuropathic pain.
    Heyn J; Luchting B; Hinske LC; Hübner M; Azad SC; Kreth S
    J Neuroinflammation; 2016 Sep; 13(1):248. PubMed ID: 27646435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNAs from
    Baulina N; Osmak G; Kiselev I; Popova E; Boyko A; Kulakova O; Favorova O
    Cells; 2019 Feb; 8(2):. PubMed ID: 30743997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation.
    Chen C; Zhou Y; Wang J; Yan Y; Peng L; Qiu W
    Front Immunol; 2018; 9():1256. PubMed ID: 29915595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of MicroRNAs in Development and Function of Regulatory T Cells - Lessons for a Better Understanding of MicroRNA Biology.
    Kunze-Schumacher H; Krueger A
    Front Immunol; 2020; 11():2185. PubMed ID: 33013919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs are key regulators controlling iNKT and regulatory T-cell development and function.
    Zhou L; Park JJ; Zheng Q; Dong Z; Mi Q
    Cell Mol Immunol; 2011 Sep; 8(5):380-7. PubMed ID: 21822298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod increases CD39-expressing regulatory T cells in multiple sclerosis patients.
    Muls N; Dang HA; Sindic CJ; van Pesch V
    PLoS One; 2014; 9(11):e113025. PubMed ID: 25411844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs and their Implications in CD4+ T-cells, Oligodendrocytes and Dendritic Cells in Multiple Sclerosis Pathogenesis.
    Safari A; Madadi S; Schwarzenbach H; Soleimani M; Safari A; Ahmadi M; Soleimani M
    Curr Mol Med; 2023 May; 23(7):630-647. PubMed ID: 35619281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-126: a novel route for natalizumab action?
    Meira M; Sievers C; Hoffmann F; Derfuss T; Kuhle J; Kappos L; Lindberg RL
    Mult Scler; 2014 Sep; 20(10):1363-70. PubMed ID: 24598267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
    Sanders KA; Benton MC; Lea RA; Maltby VE; Agland S; Griffin N; Scott RJ; Tajouri L; Lechner-Scott J
    Clin Epigenetics; 2016; 8(1):87. PubMed ID: 27570566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
    Sheng WH; Sheng KT; Zhao YX; Li H; Zhou JL; Yao HY; Li XH
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3635-42. PubMed ID: 26502853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of Pathogenic Th17 Cells Is Negatively Regulated by Let-7 MicroRNAs in a Mouse Model of Multiple Sclerosis.
    Angelou CC; Wells AC; Vijayaraghavan J; Dougan CE; Lawlor R; Iverson E; Lazarevic V; Kimura MY; Peyton SR; Minter LM; Osborne BA; Pobezinskaya EL; Pobezinsky LA
    Front Immunol; 2019; 10():3125. PubMed ID: 32010153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs are dysregulated in peripheral blood mononuclear cells in multiple sclerosis and correlate with T cell mediators.
    Perdaens O; van Pesch V
    J Neuroimmunol; 2024 Jan; 386():578196. PubMed ID: 38101084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.